GlaxoSmithkline Consumer Healthcare Ltd (GSKCH) today posted 29.27% rise in net profit at Rs 106.60 for the second quarter ended June 30, primarily on increased penetration across categories.
The company had reported a net profit of Rs 82.46 crore for the same period of previous year.
The company follows January-December financial year.
Net sales of the company rose to Rs 729.73 crore during the second quarter, as against Rs 653.38 crore during the same period of previous year, GSKCH said in a statement.
"GSKCH has shown consistent double digit growth over the years and the results of this quarter are also in-line with the company's strong performance," GSKCH Managing Director Zubair Ahmed said.
He added the company was continuously focusing on innovation and leveraging science to develop products for its expanding consumer base.
"Along with these, our cost efficiency initiatives and increased penetration across categories have helped us deliver superior results in a challenging business environment," Ahmed said.
Shares of GlaxoSmithkline Consumer Healthcare today closed at Rs 2,668.05 on the BSE, up 1.10% from its previous close. PTI MSS RAH ns